Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance

Insurers from Cigna to Aetna jump as merger mania catches on

Your article was successfully shared with the contacts you provided.

(Bloomberg) — Shares of health insurers from Cigna Corp. (NYSE:CI) to Aetna Inc. (NYSE:AET) surged on speculation that the industry is heading for a round of mergers to boost profits.

See also: Humana’s baby-boomer focus could make insurer a prize for Cigna

Anthem Inc. (NYSE:ANTM) has explored a takeovers of smaller health-insurance rivals Cigna and Humana Inc. (NYSE:HUM), a person with knowledge of the matter said, asking not to be identified discussing private information. In a third possible combination, Humana has also drawn interest from Aetna Inc., another person said.

Cigna rose as much as 19 percent and Aetna climbed as much as 7.2 percent. Anthem’s interest in Cigna was reported earlier by the Wall Street Journal, which also said UnitedHealth Group Inc. (NYSE:UNH) may be interested in a deal for Aetna or Cigna, citing people familiar with the matter.

The reports add to the drumbeat for consolidation in the health-insurance industry. Humana is already exploring a sale after being approached by Cigna about a potential deal, Bloomberg News reported last month, citing a person with knowledge of the matter. Humana offers Cigna a way to gain the lead in the market for Medicare Advantage policies, the health insurer-run version of the U.S.’s program to cover the elderly and disabled.

Jon Sandberg, a spokesman for Cigna, and Kristin Binns, a spokeswoman for Anthem, declined to comment to Bloomberg News. Tyler Mason at UnitedHealth and Cynthia Michener at Aetna also declined to comment.

Health insurers in the U.S. have been trading near all-time highs after enjoying an influx of new business from the Patient Protection and Affordable Care Act (PPACA), which brought previously uninsured people into the market for the first time. At the same time, the law put pressure on profit margins by imposing new fees on the companies and mandating that they spend at least 80 percent to 85 percent of premiums on medical claims.

With the initial surge of Obamacare enrollment now leveling off, the companies are looking at mergers to cut costs and keep profits expanding.

The Supreme Court is preparing to issue a ruling, on King vs. Burwell, and the U.S. Department of Health and Human Services (HHS) is preparing to give health insurers information about PPACA risk-adjustment program cash flows. 

See also: PPACA three R’s programs: Insurers cry out

The King vs. Burwell ruling and the risk-adjustment program news could affect companies’ appetite for deals. In some cases, for example, an insurer that believes it will be paying a large sum of risk program money to help a competitor may view acquiring the competitor as a strategy for maximizing the return on risk program payments.

‘Crazy times’

Cigna rebuffed the latest offer from Anthem for about $175 a share, the Wall Street Journal said, citing people familiar with the discussions.

Buying Cigna would help Anthem expand in employer-provided health insurance and in overseas markets. Cigna provides insurance to employees of U.S. companies working internationally and also sells products in countries such as South Korea. Anthem sells coverage under the BlueCross BlueShield brand in states including California, Georgia, New York and Connecticut.

“Strategically the transaction would improve the competitive position of both concerns,” Chris Rigg, an analyst at Susquehanna Financial Group, said in a research note.

See also: S&P sees PPACA risk corridors program funding gap

Amid speculation of consolidation in the industry, analysts have been working to figure out how the deal frenzy will shake out. If Anthem targets Cigna, Aetna is likely to pursue Humana, Rigg said.

“Alternatively, if Cigna really doesn’t want to sell, then the obvious defense is to buy Humana at any cost,” he said. “Crazy times.”

—With assistance from Michelle Fay Cortez in Minneapolis.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.